Dr. Marzia Cremona – Using Functional Data Analysis to Better Understand COVID-19 Mortality

Jun 8, 2022 | health and medicine, trending

Original Article Reference

This SciPod is a summary of the paper ‘Functional data analysis characterizes the shapes of the first COVID-19 epidemic wave in Italy’, published in Scientific Reports. DOI: https://doi.org/10.1038/s41598-021-95866-y

About this episode

Italy was the first European country to experience a major outbreak of COVID-19. Across the country, intriguingly different patterns of mortality were seen across regions. Dr. Marzia Cremona from Université Laval, in collaboration with a global team of researchers from the Pennsylvania State University and the Sant’Anna School of Advanced Studies, used novel statistical tools from the field of functional data analysis (FDA) to identify several important factors contributing to these differences. This work has critical implications for policymaking and also demonstrates the useful application of FDA techniques to epidemiological research.

 

 

 

 

This work is licensed under a Creative Commons Attribution 4.0 International LicenseCreative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.

More episodes

Professor Lobelia Samavati | Paving the Way for Antibody-based Diagnostics for Tuberculosis and Sarcoidosis

Professor Lobelia Samavati | Paving the Way for Antibody-based Diagnostics for Tuberculosis and Sarcoidosis

Tuberculosis – or TB – is a global health threat, with 10 million new cases annually. Diagnosing TB can be a challenge, as there is a lack of rapid, point-of-care diagnostic tests. It can also be difficult to distinguish between TB and other inflammatory diseases, such as Sarcoidosis. One option may be to identify antibodies in patient samples that can reveal the presence of TB. However, current antibody tests for TB lack accuracy. Professor Lobelia Samavati and colleagues at the Wanye State University School of Medicine in Michigan are tackling this challenge to cast light on the immune signature of these diseases. Their aim is to develop new diagnostic techniques for TB and Sarcoidosis.

Dr Abayomi Sanusi | Can Faith Institutions Encourage People to Maintain Healthy Blood Pressure?

Dr Abayomi Sanusi | Can Faith Institutions Encourage People to Maintain Healthy Blood Pressure?

High blood pressure, also known as hypertension, is a common and potentially dangerous condition that increases the risk of many severe medical issues, including heart disease, heart attack, stroke, heart failure, and kidney disease. Dr Abayomi Sanusi, a researcher at the University of York, recently carried out a study exploring how faith-based institutions could encourage their community members to adopt healthy behaviours that can reduce hypertension.

Ria Nishikawara | Exploring How to Improve Healthcare for Patients with Fibromyalgia

Ria Nishikawara | Exploring How to Improve Healthcare for Patients with Fibromyalgia

Fibromyalgia is a relatively common and yet poorly understood condition characterised by chronic diffuse pain and stiffness, chronic fatigue, poor sleep and cognitive difficulties. Ria Nishikawara at the University of British Columbia and her collaborators Dr Izabela Schultz, Dr Lee Butterfield, and John Murray, carried out a study exploring the unique healthcare experiences of patients diagnosed with fibromyalgia. Their aim was to determine what patients found most helpful and how the available services could be improved.

Addressing antimalarial drug resistance in Africa to ensure patients can continue to be saved

Addressing antimalarial drug resistance in Africa to ensure patients can continue to be saved

We are pleased to be joined by Dorothy Achu, Regional Malaria Adviser, WHO African Region; Aimable Mbituyumuremyi, Director, National Malaria Control Program, Ministry of Health, Rwanda; Adam Aspinall, Senior Director, Access and Product Management, and George Jagoe, Executive Vice-President Medicines for Malaria Venture. To learn about antimalarial drug resistance in Africa to ensure patients can continue to be saved.

Increase the impact of your research

• Good science communication helps people make informed decisions and motivates them to take appropriate and affirmative action.
• Good science communication encourages everyday people to be scientifically literate so that they can analyse the integrity and legitimacy of information.
• Good science communication encourages people into STEM-related fields of study and employment.
• Good public science communication fosters a community around research that includes both members of the public, policymakers and scientists.
• In a recent survey, 75% of people suggested they would prefer to listen to an interesting story than read it.

Step 1 Upload your science paper

Step 2 SciPod script written

Step 3 Voice audio recorded

Step 4 SciPod published